PC

Pentwater Capital Management

North America, Florida, United States, Naples

Description

Pentwater Capital Management Is an investment firm

Investor Profile

Pentwater Capital Management has backed more than 2 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States, Denmark.
  • Strong thematic focus on Biotechnology, Biopharma, Genetics.

Stage Focus

  • Series C (50%)
  • Post Ipo Equity (50%)

Country Focus

  • United States (50%)
  • Denmark (50%)

Industry Focus

  • Biotechnology
  • Biopharma
  • Genetics
  • Therapeutics
  • Collaboration
  • Pet
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pentwater Capital Management frequently co-invest with?

Rapha Capital Management
North America, New York, United States, Florida
Co-Investments: 1
Novartis
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Malin Corporation
Europe, Dublin, Ireland, Dublin
Co-Investments: 1
Longitude Capital
North America, California, United States, Menlo Park
Co-Investments: 1
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 1
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 1
Aisling Capital
North America, New York, United States, New York
Co-Investments: 1
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 1

What are some of recent deals done by Pentwater Capital Management?

Curasight A/S

Copenhagen, Hovedstaden, Denmark

Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several cancer indications.

BiotechnologyCollaborationPet
Post Ipo EquityMay 21, 2025
Amount Raised: $7,139,030
Poseida Therapeutics

San Diego, California, United States

Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.

BiopharmaBiotechnologyGeneticsTherapeutics
Series CApr 22, 2019
Amount Raised: $142,000,000